Loading…

Do children benefit from mass screening for neuroblastoma?

The effectiveness of mass screening for neuroblastoma among children has not been proven.

Saved in:
Bibliographic Details
Published in:The Lancet (British edition) 1991-02, Vol.337 (8737), p.344-346
Main Authors: Murphy, S.B, Cohn, S.L, Craft, A.W, Woods, W.G, Sawada, T, Castleberry, R.P, Levy, H.L, Prorok, P.C, Hammond, G.D
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c1232-4220c342fa4539cd5741daf8949e18f350d84874675934b32995d448ded896d33
cites cdi_FETCH-LOGICAL-c1232-4220c342fa4539cd5741daf8949e18f350d84874675934b32995d448ded896d33
container_end_page 346
container_issue 8737
container_start_page 344
container_title The Lancet (British edition)
container_volume 337
creator Murphy, S.B
Cohn, S.L
Craft, A.W
Woods, W.G
Sawada, T
Castleberry, R.P
Levy, H.L
Prorok, P.C
Hammond, G.D
description The effectiveness of mass screening for neuroblastoma among children has not been proven.
doi_str_mv 10.1016/0140-6736(91)90957-Q
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_199010302</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1692841</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1232-4220c342fa4539cd5741daf8949e18f350d84874675934b32995d448ded896d33</originalsourceid><addsrcrecordid>eNo90M1KAzEUhuEgCtbqHbgIrnQxepKcTCZuROovFKSg4C5kJolO6UxqMrPw7m2tuDqbl_PBQ8gpg0sGrLwChlCUSpTnml1o0FIViz0yYaiwkKje98nkPzkkRzkvAQBLkBNyfRdp89muXPI9rX3vQzvQkGJHO5szzU3yvm_7Dxpior0fU6xXNg-xszfH5CDYVfYnf3dK3h7uX2dPxfzl8Xl2Oy8axgUvkHNoBPJgUQrdOKmQORsqjdqzKggJrsJKYamkFlgLrrV0iJXzrtKlE2JKznZ_1yl-jT4PZhnH1G8mDdMaGAjgmwh3UZNizskHs05tZ9O3YWC2SGYrYLYCRjPzi2QW4gdPS1gW</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>199010302</pqid></control><display><type>article</type><title>Do children benefit from mass screening for neuroblastoma?</title><source>EBSCOhost Business Source Ultimate</source><creator>Murphy, S.B ; Cohn, S.L ; Craft, A.W ; Woods, W.G ; Sawada, T ; Castleberry, R.P ; Levy, H.L ; Prorok, P.C ; Hammond, G.D</creator><creatorcontrib>Murphy, S.B ; Cohn, S.L ; Craft, A.W ; Woods, W.G ; Sawada, T ; Castleberry, R.P ; Levy, H.L ; Prorok, P.C ; Hammond, G.D</creatorcontrib><description>The effectiveness of mass screening for neuroblastoma among children has not been proven.</description><identifier>ISSN: 0140-6736</identifier><identifier>EISSN: 1474-547X</identifier><identifier>DOI: 10.1016/0140-6736(91)90957-Q</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>London: Elsevier Limited</publisher><subject>Cancer ; Children &amp; youth ; Health care ; Public health</subject><ispartof>The Lancet (British edition), 1991-02, Vol.337 (8737), p.344-346</ispartof><rights>Copyright Lancet Ltd. Feb 9, 1991</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1232-4220c342fa4539cd5741daf8949e18f350d84874675934b32995d448ded896d33</citedby><cites>FETCH-LOGICAL-c1232-4220c342fa4539cd5741daf8949e18f350d84874675934b32995d448ded896d33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Murphy, S.B</creatorcontrib><creatorcontrib>Cohn, S.L</creatorcontrib><creatorcontrib>Craft, A.W</creatorcontrib><creatorcontrib>Woods, W.G</creatorcontrib><creatorcontrib>Sawada, T</creatorcontrib><creatorcontrib>Castleberry, R.P</creatorcontrib><creatorcontrib>Levy, H.L</creatorcontrib><creatorcontrib>Prorok, P.C</creatorcontrib><creatorcontrib>Hammond, G.D</creatorcontrib><title>Do children benefit from mass screening for neuroblastoma?</title><title>The Lancet (British edition)</title><description>The effectiveness of mass screening for neuroblastoma among children has not been proven.</description><subject>Cancer</subject><subject>Children &amp; youth</subject><subject>Health care</subject><subject>Public health</subject><issn>0140-6736</issn><issn>1474-547X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><recordid>eNo90M1KAzEUhuEgCtbqHbgIrnQxepKcTCZuROovFKSg4C5kJolO6UxqMrPw7m2tuDqbl_PBQ8gpg0sGrLwChlCUSpTnml1o0FIViz0yYaiwkKje98nkPzkkRzkvAQBLkBNyfRdp89muXPI9rX3vQzvQkGJHO5szzU3yvm_7Dxpior0fU6xXNg-xszfH5CDYVfYnf3dK3h7uX2dPxfzl8Xl2Oy8axgUvkHNoBPJgUQrdOKmQORsqjdqzKggJrsJKYamkFlgLrrV0iJXzrtKlE2JKznZ_1yl-jT4PZhnH1G8mDdMaGAjgmwh3UZNizskHs05tZ9O3YWC2SGYrYLYCRjPzi2QW4gdPS1gW</recordid><startdate>19910209</startdate><enddate>19910209</enddate><creator>Murphy, S.B</creator><creator>Cohn, S.L</creator><creator>Craft, A.W</creator><creator>Woods, W.G</creator><creator>Sawada, T</creator><creator>Castleberry, R.P</creator><creator>Levy, H.L</creator><creator>Prorok, P.C</creator><creator>Hammond, G.D</creator><general>Elsevier Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>ASE</scope><scope>C1K</scope><scope>FPQ</scope><scope>H94</scope><scope>K6X</scope><scope>K9.</scope><scope>KB~</scope><scope>M7N</scope><scope>NAPCQ</scope></search><sort><creationdate>19910209</creationdate><title>Do children benefit from mass screening for neuroblastoma?</title><author>Murphy, S.B ; Cohn, S.L ; Craft, A.W ; Woods, W.G ; Sawada, T ; Castleberry, R.P ; Levy, H.L ; Prorok, P.C ; Hammond, G.D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1232-4220c342fa4539cd5741daf8949e18f350d84874675934b32995d448ded896d33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Cancer</topic><topic>Children &amp; youth</topic><topic>Health care</topic><topic>Public health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Murphy, S.B</creatorcontrib><creatorcontrib>Cohn, S.L</creatorcontrib><creatorcontrib>Craft, A.W</creatorcontrib><creatorcontrib>Woods, W.G</creatorcontrib><creatorcontrib>Sawada, T</creatorcontrib><creatorcontrib>Castleberry, R.P</creatorcontrib><creatorcontrib>Levy, H.L</creatorcontrib><creatorcontrib>Prorok, P.C</creatorcontrib><creatorcontrib>Hammond, G.D</creatorcontrib><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>British Nursing Index</collection><collection>Environmental Sciences and Pollution Management</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>British Nursing Index</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Newsstand Professional</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>The Lancet (British edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Murphy, S.B</au><au>Cohn, S.L</au><au>Craft, A.W</au><au>Woods, W.G</au><au>Sawada, T</au><au>Castleberry, R.P</au><au>Levy, H.L</au><au>Prorok, P.C</au><au>Hammond, G.D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Do children benefit from mass screening for neuroblastoma?</atitle><jtitle>The Lancet (British edition)</jtitle><date>1991-02-09</date><risdate>1991</risdate><volume>337</volume><issue>8737</issue><spage>344</spage><epage>346</epage><pages>344-346</pages><issn>0140-6736</issn><eissn>1474-547X</eissn><coden>LANCAO</coden><abstract>The effectiveness of mass screening for neuroblastoma among children has not been proven.</abstract><cop>London</cop><pub>Elsevier Limited</pub><doi>10.1016/0140-6736(91)90957-Q</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0140-6736
ispartof The Lancet (British edition), 1991-02, Vol.337 (8737), p.344-346
issn 0140-6736
1474-547X
language eng
recordid cdi_proquest_journals_199010302
source EBSCOhost Business Source Ultimate
subjects Cancer
Children & youth
Health care
Public health
title Do children benefit from mass screening for neuroblastoma?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T14%3A56%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Do%20children%20benefit%20from%20mass%20screening%20for%20neuroblastoma?&rft.jtitle=The%20Lancet%20(British%20edition)&rft.au=Murphy,%20S.B&rft.date=1991-02-09&rft.volume=337&rft.issue=8737&rft.spage=344&rft.epage=346&rft.pages=344-346&rft.issn=0140-6736&rft.eissn=1474-547X&rft.coden=LANCAO&rft_id=info:doi/10.1016/0140-6736(91)90957-Q&rft_dat=%3Cproquest_cross%3E1692841%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1232-4220c342fa4539cd5741daf8949e18f350d84874675934b32995d448ded896d33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=199010302&rft_id=info:pmid/&rfr_iscdi=true